Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02080572 · ClinicalTrials.gov registry record

Parkinstep: Automated PD Gait and Balance Assessment for Optimizing DBS

A clinical trial, sponsored by Great Lakes NeuroTechnologies.

Completed
Registry status
22
Enrollment target

NCT02080572: Completed study, sponsored by Great Lakes NeuroTechnologies.

NCT02080572 is a clinical trial that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02080572 has completed, sponsored by Great Lakes NeuroTechnologies.

COMPLETED
Registry status
22 participants
Enrollment target

Study Summary

Changes in deep brain stimulation (DBS) settings can have a delayed effect on gait function, which makes it impractical to optimize DBS for gait parameters in the clinic. Wearable movement sensors could be used to assess gait impairment in the patient's home hours after treatment adjustments are made in the clinic. This study aims to quantitatively evaluate the effects of turning off deep brain stimulation on lower extremity and gait function over three hours. This study will provide vital information about our patient worn system's ability to detect changes in lower impairment over time, which could be used to assist with DBS tuning for the lower extremities and gait in the future.

Primary Outcome

Motor function evaluations (movement speed and magnitude) will be collected at various time points after DBS cessation. The effects over time will be examined.

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2014-02
Great Lakes NeuroTechnologies

17 total trials

What the finished NCT02080572 record still lists

NCT02080572 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT02080572 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02080572 about?

NCT02080572 is a clinical study titled "Parkinstep: Automated PD Gait and Balance Assessment for Optimizing DBS". Changes in deep brain stimulation (DBS) settings can have a delayed effect on gait function, which makes it impractical to optimize DBS for gait parameters in the clinic. Wearable movement sensors could be used to assess gait impairment in the patient's home hours after treatment adjustments are mad...

What is the current status of trial NCT02080572?

This trial is currently completed. The enrollment target is 22 participants. The study started on 2014-02.

Who is sponsoring clinical trial NCT02080572?

This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02080572, the US trial registry maintained by the National Library of Medicine. NCT02080572 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.